TENX   $4.93  1.65% Market Closed

Tenax Therapeutics Inc
Last Events:

2023-08-09 Trend pattern changed from симметричный треугольник to восходящий треугольник.

2023-08-09 Signal in RSI changed from bearish recovery to bearish weakening. RSI indicator is in the lower part of the neutral territory and it heading north. These factors indicate that the upside trend is forming Last signal: exit from the overbought zone.

2023-08-06 Trend pattern changed from нисходящий треугольник to симметричный треугольник.

2023-08-06 Signal in RSI changed from bearish weakening to bearish recovery. RSI indicator is in the lower part of the neutral territory and it heading south. These factors indicate that negative dynamics is recovering. Last signal: exit from the overbought zone.

2023-08-05 Trend pattern changed from расходящийся клин с наклоном вниз to нисходящий треугольник.

2023-08-05 Signal in RSI changed from bearish to bearish weakening. RSI indicator is in the lower part of the neutral territory and it heading north. These factors indicate that the upside trend is forming Last signal: exit from the overbought zone.

2023-08-04 Signal in Stochastic changed from bullish weakening to bearish. The stochastic indicator is in the lower part of the neutral territory and it falls. These factors indicate that negative dynamics persists. Last signal: down-crossing the middle level.

2023-08-04 Signal in MACD changed from bearish reversal to bearish. Oscillator MACD is in the negative territory it's lower than the signal line and it crossed the zero line from the top. These factors mean that there is probably a falling trend. Last signal: down-crossing the middle level.


Current temperature: 4.30
ST: 0, Cor:

Analyst Recommendations:
Number of estimates 4
Target Price Mean 17.25
Mean unverified/preliminary 17.25 / 17.25
Target Price Low / High 7.00 / 30.00
Median / STD DEV 16.00 / 9.50
Tech Forecasts:
More signals
  < 1M 1-3M > 3M
total ActivelyBuy ActivelyBuy ActivelyBuy
rsi ActivelyBuy ActivelyBuy None
macd None ActivelyBuy None
stoch ActivelyBuy None None
ma20 ActivelyBuy ActivelyBuy ActivelyBuy
ma50 ActivelyBuy None None
ma100 Buy ActivelyBuy None
Candlestick PatternNov. 20, 2024 Three Stars -
ISIN US88032L6056
ceo Mr. Christopher T. Giordano
Website https://www.tenaxthera.com
Tenax Therapeutics, Inc. develops and commercializes pharmaceutical products containing imatinib for the treatment of pulmonary arterial hypertension in the United States. The company develops TNX-101 (IV), TNX-102, and TNX-103 (levosimendan) that have completed phase II clinical trials for the treatment of patients with pulmonary hypertension associated with heart failure with preserved ejection fraction and associated pulmonary hypertension; and TNX-201 (imatinib), a tyrosine kinase inhibitor for the treatment of chronic myeloid leukemia. The company was formerly known as Oxygen Biotherapeutics, Inc. and changed its name to Tenax Therapeutics, Inc. in September 2014. Tenax Therapeutics, Inc. was founded in 1967 and is based in Chapel Hill, North Carolina.